Humacyte, Inc. Common Stock

HUMANASDAQUSD
0.70 USD
0.04 (5.89%)AT CLOSE (11:59 AM EDT)
0.70
0.00 (0.03%)
POST MARKET (AS OF 07:49 PM EDT)
Post Market
AS OF 07:49 PM EDT
0.70
0.00 (0.03%)
🟢Market: OPEN

Shares of Humacyte, Inc. Common Stock (HUMA) are trading at $0.70. There is a divergence between signals — technical indicators rate "Buy" but underlying fundamentals lean "Sell". This is driven by a concerning Altman Z-Score in the distress zone, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation front, HUMA trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.

Technical & fundamental data as of Aug 25, 2026.

Open?$0.66
High?$0.73
Low?$0.66
Prev. Close?$0.66
Volume?5.9M
Avg. Volume?7.6M
VWAP?$0.70
Rel. Volume?0.78x
Bid / Ask
Bid?$0.60 × 100
Ask?$3.00 × 100
Spread?$2.40
Midpoint?$1.80
Valuation & Ratios
Market Cap?183.3M
Shares Out?277.8M
Float?245.5M
Float %?88.4%
P/E Ratio?N/A
P/B Ratio?5.87
EPS?-$0.35
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
Employees
184
Market Cap
184.0M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2021-08-27
Address
2525 EAST NORTH CAROLINA HIGHWAY 54
DURHAM, NC 27713
Phone: 919-313-9633
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Neutral(0/3)
Medium-Term (Wave)? Bullish(+1/3)
Short-Term (Ripple)? Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
0
Momentum?
57
Short Sent.?
50
Piotroski F-Score?4/9Mixed
Altman Z-Score?-8.92Distress
Confidence?55%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?13.01%High
Short Interest?31.9M
Days to Cover?3.4
Free Float245.5M
Avg Daily Volume9.5M
Settlement Date2026-08-14
Financial Health
Current Ratio?6.21Strong
Quick Ratio?5.74Strong
Cash Ratio?5.35Strong
Debt/Equity?2.12High
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A
P/B?
Peers
100
S&P
31
5.87FAIR
P/S?
Peers
100
S&P
3
86.44HIGH
P/FCF?
N/A
EV/EBITDA?
S&P
97
-1.6CHEAP
EV/Sales?
Peers
100
S&P
3
79.97HIGH
Returns & Efficiency
ROE?
S&P
3
-309.4%WEAK
ROA?
S&P
3
-70.1%WEAK
Cash Flow & Enterprise
FCF?$-97560000
Enterprise Value?$169.6M
Fundamentals ratios updated end of day